Search

Author/Creator Bergenstal, Richard M.

2. Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin. Issue 3 (September 2016)

Authors:
White, William B.; Wilson, Craig A.; Bakris, George L.; Bergenstal, Richard M.; Cannon, Christopher P.; Cushman, William C.; Heller, Simon K.; Mehta, Cyrus R.; Nissen, Steven E.; Zannad, Faiez; Kupfer, Stuart
Journal:
Hypertension
Issue:
Volume 68:Issue 3(2016:Sep.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia. (July 2013)

Authors:
Klonoff, David C.; Bergenstal, Richard M.; Garg, Satish K.; Bode, Bruce W.; Meredith, Melissa; Slover, Robert H.; Ahmann, Andrew; Welsh, John B.; Lee, Scott W.
Journal:
Journal of diabetes science and technology
Issue:
Volume 7:Number 4(2013)
Page Start:
1005
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles. (September 2022)

Authors:
Bergenstal, Richard M.; Johnson, Mary L.; Aroda, Vanita R.; Brazg, Ronald L.; Dreon, Darlene M.; Frias, Juan P.; Kruger, Davida F.; Molitch, Mark E.; Mullen, Deborah M.; Peyrot, Mark; Richter, Sara; Rosenstock, Julio; Serusclat, Pierre; Vance, Carl; Weinstock, Ruth S.; Levy, Brian L.
Journal:
Journal of diabetes science and technology
Issue:
Volume 16:Number 5(2022)
Page Start:
1167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed‐ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan‐L trial. Issue 10 (8th June 2017)

Authors:
Wysham, Carol; Bonadonna, Riccardo C.; Aroda, Vanita R.; Puig Domingo, Manuel; Kapitza, Christoph; Stager, William; Yu, Christine; Niemoeller, Elisabeth; Souhami, Elisabeth; Bergenstal, Richard M.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 10(2017)
Page Start:
1408
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial. Issue 2 (14th November 2022)

Authors:
Battelino, Tadej; Danne, Thomas; Edelman, Steve V.; Choudhary, Pratik; Renard, Eric; Westerbacka, Jukka; Mukherjee, Bhaswati; Pilorget, Valerie; Coudert, Mathieu; Bergenstal, Richard M.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 2(2023)
Page Start:
545
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Continuous Ketone Monitoring Consensus Report 2021. (May 2022)

Authors:
Nguyen, Kevin T.; Xu, Nicole Y.; Zhang, Jennifer Y.; Shang, Trisha; Basu, Ananda; Bergenstal, Richard M.; Castorino, Kristin; Chen, Kong Y.; Kerr, David; Koliwad, Suneil K.; Laffel, Lori M.; Mathioudakis, Nestoras; Midyett, L. Kurt; Miller, Joshua D.; Nichols, James H.; Pasquel, Francisco J.; Pra...
Journal:
Journal of diabetes science and technology
Issue:
Volume 16:Number 3(2022)
Page Start:
689
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗